"Smoke 'em if ya got 'em."
FSD Pharma (HUGE) agrees...They just got FDA consent for a Phase 2a Covid19 Trial with their cannabinoid drug.
https://www.stockwatch.com/News/Item?bid=U-b20200602005990-U%3aHUGE-20200602&symbol=HUGE®ion=U
They also listed in the US in October which was working out for them for a bit. Yesterday the stock went from $4 to $14 on the FDA news. Why isn't that happening for us? Maybe pulling the US listing plans wasn't such a great move...
And here we sit at a near decade low with a recent FDA Breakthrough Therapy Designation in a major indication and the company has gone virtually dark in terms of communications. Where are the partners you keep referencing Don? Where's the news on the HIV trial partner? Where's the FDA fast track plan? Just unbeleivable.
